Topoisomerase IIα maintains genomic stability through decatenation G2 checkpoint signaling

被引:68
作者
Bower, J. J. [1 ,2 ]
Karaca, G. F. [1 ]
Zhou, Y. [1 ]
Simpson, D. A. [1 ]
Cordeiro-Stone, M. [1 ,2 ,3 ]
Kaufmann, W. K. [1 ,2 ,3 ]
机构
[1] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Ctr Environm Hlth & Susceptibil, Chapel Hill, NC 27599 USA
关键词
decatenation; G(2) checkpoint; topoisomerase II alpha; topoisomerase II beta; chromosomal instability; CELL-CYCLE; DNA TOPOISOMERASES; BREAST-CANCER; CHROMOSOME SEGREGATION; IONIZING-RADIATION; GENE-EXPRESSION; BETA; POISONS; ROLES; BISDIOXOPIPERAZINES;
D O I
10.1038/onc.2010.232
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Topoisomerase II alpha (topoII alpha) is an essential mammalian enzyme that topologically modifies DNA and is required for chromosome segregation during mitosis. Previous research suggests that inhibition of topoII decatenatory activity triggers a G(2) checkpoint response, which delays mitotic entry because of insufficient decatenation of daughter chromatids. Here we examine the effects of both topoII alpha and topoII beta on decatenatory activity in cell extracts, DNA damage and decatenation G(2) checkpoint function, and the frequencies of p16(INK4A) allele loss and gain. In diploid human fibroblast lines, depletion of topoII alpha by small-interfering RNA was associated with severely reduced decatenatory activity, delayed progression from G(2) into mitosis and insensitivity to G(2) arrest induced by the topoII catalytic inhibitor ICRF-193. Furthermore, interphase nuclei of topoII alpha-depleted cells showed increased frequencies of losses and gains of the tumor suppressor genetic locus p16(INK4A). This study shows that the topoII alpha protein is required for decatenation G(2) checkpoint function, and inactivation of decatenation and the decatenation G(2) checkpoint leads to abnormal chromosome segregation and genomic instability. Oncogene (2010) 29, 4787-4799; doi:10.1038/onc.2010.232; published online 21 June 2010
引用
收藏
页码:4787 / 4799
页数:13
相关论文
共 52 条
[1]   Enforced cytokinesis without complete nuclear division in embryonic cells depleting the activity of DNA topoisomerase IIα [J].
Akimitsu, N ;
Adachi, N ;
Hirai, H ;
Hossain, MS ;
Hamamoto, H ;
Kobayashi, M ;
Aratani, Y ;
Koyama, H ;
Sekimizu, K .
GENES TO CELLS, 2003, 8 (04) :393-402
[2]  
Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO
[3]  
2-Q
[4]   (-)-epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerases [J].
Bandele, Omari J. ;
Osheroff, Neil .
CHEMICAL RESEARCH IN TOXICOLOGY, 2008, 21 (04) :936-943
[5]   Bioflavonoids as poisons of human topoisomerase IIα and IIβ [J].
Bandele, Omari J. ;
Osheroff, Neil .
BIOCHEMISTRY, 2007, 46 (20) :6097-6108
[6]   Topoisomerase II inactivation prevents the completion of DNA replication in budding yeast [J].
Baxter, Jonathan ;
Diffley, John F. X. .
MOLECULAR CELL, 2008, 30 (06) :790-802
[7]   HER-2, TOP2A and chromosome 17 alterations in breast cancer [J].
Beser, Ash Rehber ;
Tuzlali, Sitki ;
Guzey, Deniz ;
Guler, Semra Dolek ;
Hacihanefioglu, Seniha ;
Dalay, Nejat .
PATHOLOGY & ONCOLOGY RESEARCH, 2007, 13 (03) :180-185
[8]   Active heterodimers are formed from human DNA topoisomerase II alpha and II beta isoforms [J].
Biersack, H ;
Jensen, S ;
Gromova, I ;
Nielsen, IS ;
Westergaard, O ;
Andersen, AH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) :8288-8293
[9]   Revised genetic requirements for the decatenation G2 checkpoint The role of ATM [J].
Bower, Jacquelyn J. ;
Zhou, Yingchun ;
Zhou, Tong ;
Simpson, Dennis A. ;
Arlander, Sonnet J. ;
Paules, Richard S. ;
Cordeiro-Stone, Marila ;
Kaufmann, William K. .
CELL CYCLE, 2010, 9 (08) :1617-1628
[10]   Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme [J].
Burden, DA ;
Osheroff, N .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :139-154